Biospain 2023: Remab Therapeutics y Biointaxis

from Biotecnología Capital · host Capital Radio

Presentamos dos nuevas empresas con el presidente de Remab, Rafael Máñez y también descubrimos a Biointaxis con su CEO, Antoni Matilla.

Episode metadata supplied by the publisher feed · Published Oct 9, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Biospain 2023: Remab Therapeutics y Biointaxis

0:00 23:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 23 minutes long.

This episode was published on October 9, 2023.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!